Archives for February 24, 2022

← 2022

Moderna and Thermo Fisher Scientific announce 15-year mRNA manufacturing deal

24-Feb-2022

By Rachel Arthur

Moderna and Thermo Fisher Scientific have announced a 15-year strategic collaboration agreement to enable dedicated large-scale manufacturing of COVID-19 vaccine Spikevax in the US, as well as other investigational mRNA vaccines and therapies.

Developer of therapeutic strategies for thrombosis raises millions in Series A round

24-Feb-2022

By Jane Byrne

TargED Biopharmaceuticals, a spin-off from the University Medical Center Utrecht that is developing therapies to improve treatment of thrombosis, has raised Series A financing of €39m (US$44.1m)